Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on Ankylosing Spondylitis: What is it?
Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, leading to pain, stiffness, and reduced mobility. Over time, AS can cause the vertebrae in the spine to fuse, resulting in a loss of flexibility and a hunched-forward posture. The disease often begins in early adulthood, and its hallmark symptom is persistent lower back pain that improves with movement but worsens with rest.
AS is considered an autoimmune disorder, with a strong genetic link, particularly with the HLA-B27 gene. In addition to affecting the spine, AS can cause inflammation in other areas such as the hips, shoulders, and even organs like the eyes (uveitis). Early diagnosis is critical to managing AS, as treatment focuses on reducing pain and inflammation, preventing or delaying spinal fusion, and maintaining posture. Treatment options include NSAIDs, physical therapy, and biologics, such as TNF inhibitors, to control inflammation and preserve mobility.
Therefore, get an overall knowledge of ankylosing spondylitis: what is it?
See More Webinars @ Hidoc Webinars
1.
Newly identified T-cell subtype may explain treatment-resistant childhood leukemia
2.
Glioblastoma treatment breakthrough shows promise
3.
A computer-aided diagnostic system for improved detection of breast cancer.
4.
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy
5.
Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.
1.
Liquid Biopsies in Hematology: A Window into the Disease
2.
Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology
3.
A Visual Guide to Understanding Breast Cancer Staging
4.
Exploring the Latest Treatments for Essential Thrombocythemia
5.
Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
3.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
Navigating the Complexities of Ph Negative ALL - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation